13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lipid rafts are critical cell membrane lipid platforms enriched in sphingolipid and cholesterol content involved in diverse cellular processes. They have been proposed to influence membrane properties and to accommodate receptors within themselves by facilitating their interaction with ligands. Over the past decade, technical advances have improved our understanding of lipid rafts as bioactive structures. In this review, we will cover the more recent findings about cholesterol, sphingolipids and lipid rafts located in cellular and nuclear membranes in cancer. Collectively, the data provide insights on the role of lipid rafts as biomolecular targets in cancer with good perspectives for the development of innovative therapeutic strategies.

          Related collections

          Most cited references148

          • Record: found
          • Abstract: found
          • Article: not found

          Cancer-related inflammation.

          The mediators and cellular effectors of inflammation are important constituents of the local environment of tumours. In some types of cancer, inflammatory conditions are present before a malignant change occurs. Conversely, in other types of cancer, an oncogenic change induces an inflammatory microenvironment that promotes the development of tumours. Regardless of its origin, 'smouldering' inflammation in the tumour microenvironment has many tumour-promoting effects. It aids in the proliferation and survival of malignant cells, promotes angiogenesis and metastasis, subverts adaptive immune responses, and alters responses to hormones and chemotherapeutic agents. The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Tumor-associated macrophages: from mechanisms to therapy.

            The tumor microenvironment is a complex ecology of cells that evolves with and provides support to tumor cells during the transition to malignancy. Among the innate and adaptive immune cells recruited to the tumor site, macrophages are particularly abundant and are present at all stages of tumor progression. Clinical studies and experimental mouse models indicate that these macrophages generally play a protumoral role. In the primary tumor, macrophages can stimulate angiogenesis and enhance tumor cell invasion, motility, and intravasation. During monocytes and/or metastasis, macrophages prime the premetastatic site and promote tumor cell extravasation, survival, and persistent growth. Macrophages are also immunosuppressive, preventing tumor cell attack by natural killer and T cells during tumor progression and after recovery from chemo- or immunotherapy. Therapeutic success in targeting these protumoral roles in preclinical models and in early clinical trials suggests that macrophages are attractive targets as part of combination therapy in cancer treatment. Copyright © 2014 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Sphingolipids and their metabolism in physiology and disease

              Studies of bioactive lipids in general and sphingolipids in particular have intensified over the past several years, revealing an unprecedented and unanticipated complexity of the lipidome and its many functions, which rivals, if not exceeds, that of the genome or proteome. These results highlight critical roles for bioactive sphingolipids in most, if not all, major cell biological responses, including all major cell signalling pathways, and they link sphingolipid metabolism to key human diseases. Nevertheless, the fairly nascent field of bioactive sphingolipids still faces challenges in its biochemical and molecular underpinnings, including defining the molecular mechanisms of pathway and enzyme regulation, the study of lipid-protein interactions and the development of cellular probes, suitable biomarkers and therapeutic approaches.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                13 January 2021
                January 2021
                : 22
                : 2
                : 726
                Affiliations
                [1 ]Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy; michela.codini@ 123456unipg.it
                [2 ]Department of Biology, University of Pisa, 56127 Pisa, Italy; mercedes.garcia@ 123456unipi.it
                [3 ]Interdepartmental Research Center Nutrafood, Nutraceuticals and Food for Health, University of Pisa, 56127 Pisa, Italy
                Author notes
                [* ]Correspondence: elisabetta.albi@ 123456unipg.it ; Tel./Fax: +39-0755857940
                Author information
                https://orcid.org/0000-0002-1562-4495
                https://orcid.org/0000-0002-1344-2786
                https://orcid.org/0000-0002-5745-5343
                Article
                ijms-22-00726
                10.3390/ijms22020726
                7828315
                33450869
                320c271b-2a4a-45a9-ae96-d3c5414b5bf1
                © 2021 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 15 December 2020
                : 11 January 2021
                Categories
                Review

                Molecular biology
                cholesterol,sphingolipid,cancer,lipid raft,therapeutic target
                Molecular biology
                cholesterol, sphingolipid, cancer, lipid raft, therapeutic target

                Comments

                Comment on this article